Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result

American Journal of Gastroenterology

Volumn 98, Issue 9, 2003, Pages 2078-2081

  Baig, Nadeem ^b   Myers, Ronald E ^b   Turner, Barbara J ^b   Grana, James ^b   Rothermel, Todd ^b   Schlackman, Neil ^b   Weinberg, David S ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; MALE; MANAGED CARE; MEDICAL DECISION MAKING; OCCULT BLOOD; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SIGMOIDOSCOPY;

EID: 0141459686     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07575.x     Document Type: Article

References (21)

1. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
2. Mandel JS, Bond JS, Church TR, et al. Reducing mortality from colorectal cancer by screeening for fecal occult blood. N Engl J Med 1993;328:1365-71.
3. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecel-occult-blood test. Lancet 1996;348:1467-71.
4. Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst 1999;91:1641-6.
5. Myers RE, Turner B, Weinberg D, et al. Complete diagnostic evaluation in colorectal cancer screening: Research design and baseline findings. Prev Med 2001;33:249-60.
6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
7. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd edition. Washington, DC: U.S. Department of Health and Human Services, 1996.
8. Macrae FA, St. John DJ, Caligiore P, et al. Optimal dietary conditions for hemoccult testing. Gastroenterology 1982;82:899-903.
9. Pye G, Ballantyne KC, Armitage NC, Hardcastle JD. Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer. Br Med J 1987;294:1510-1.
10. Greenberg PD, Cello JP, Rockey DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med 1996;100:598-604.
11. Lieberman DA, Harford WV, Ahnen DJ, et al. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
12. Simon JB. Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved. N Engl J Med 1998;338:1151-2.
13. Rex DK, Cummings OW, Helper DJ, et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 1996;111:1178-81.
14. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-8.
15. Fox SA, Siu AL, Stein JA. The importance of physician communication on breast cancer screening of older women. Arch Intern Med 1994;154:2058-68.
16. Holt WS. Factors affecting compliance with screening sigmoidoscopy. J Fam Pract 1991;32:585-9.
17. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000;342:1766-72.
18. Elliot MS, Levenstein JH, Wright JP. Faecal occult blood testing in the detection of colorectal cancer. Br J Surg 1984;71:785-6.
19. Kewenter J, Brevinge H, Engaras B, Haglind E. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy 1995;27:159-63.
20. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care 1998;36:257-70.
21. Weisman CS, Henderson JT. Managed care and women's health: Access, preventive services, and satisfaction. Womens Health Issues 2001;11:201-15.